Tekla Capital Management LLC Cytokinetics Inc Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 219,025 shares of CYTK stock, worth $11.9 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
219,025
Previous 219,025
-0.0%
Holding current value
$11.9 Million
Previous $7.71 Million
7.31%
% of portfolio
0.28%
Previous 0.3%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
459Shares Held
108MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$673 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$542 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$277 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$259 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$245 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.1B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...